-
by Maryanne Griffith
The Vaccine and Immunisation Research Group at the Doherty Institute is one of four Australian study sites participating in a global phase I/II cli...
-
by Maryanne Griffith
First participants dosed in phase I/II study of Spybiotech and Serum Institute of India's virus-like particle (VLP) candidate COVID-19 vaccine.
-
by Maryanne Griffith
Vax4COVID Alliance Centres in Sydney, Adelaide and Perth will evaluate COVIGEN, the first DNA-based candidate COVID-19 vaccine to be trialled in Au...
-
by Maryanne Griffith
The University of Queensland is expanding the phase I study of its candidate COVID-19 vaccine to include an additional 96 older adult participants
-
by Maryanne Griffith
Novavax Initiates Phase II Portion of the Combined Phase I/II Study of its candidate COVID-19 Vaccine
-
by Maryanne Griffith
Novavax announces positive Phase I data for its candidate COVID-19 vaccine
-
by Maryanne Griffith
Dosing begins in the first human trial of UQ's COVID-19 vaccine.
-
by Maryanne Griffith
Clover Biopharmaceuticals Initiates Phase I Study of COVID-19 Vaccine at Linear Clinical Research in Perth, Western Australia
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
